Effect of caffeine on the vocal folds: a pilot study

被引:21
作者
Akhtar, S
Wood, G
Rubin, JS
O'Flynn, PE
Ratcliffe, P
机构
[1] Royal Natl Throat Nose & Ear Hosp, Dept Speech & Language Therapy, London WC1X 8DA, England
[2] Royal Natl Throat Nose & Ear Hosp, Dept Otolaryngol Head & Neck Surg, London WC1X 8DA, England
关键词
caffeine; dehydration; vocal fold;
D O I
10.1017/S0022215100143920
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Caffeine is considered to be a dehydrating agent with detrimental effects on the quality of voice of persons ingesting it. This has led medical personnel dealing with voice disorders, especially in the case of professional voice users, to give advice against the use of caffeine. Yet this is an anecdotal truth as an extensive Medline literature search did not reveal any scientific evidence of caffeine being proven to have adverse effects on the vocal folds. We, therefore, initiated this pilot study to ascertain the connection between caffeine and voice quality on a laboratory basis. Two hundred and fifty mg of caffeine were provided to eight volunteers in tablet form, and blood levels along with laryngograph readings were recorded to document the changes produced. Analysing the irregularities of frequencies in a) free speech b) a reading passage and c) singing 'Happy Birthday', substantial changes were seen to authenticate the fact that caffeine does produce alterations in voice quality but these alterations have considerable intrasubject variability. A full study with wider parameters is to be performed on this subject as we consider it to be of importance in the management of voice disorders.
引用
收藏
页码:341 / 345
页数:5
相关论文
共 15 条
[1]  
BARRY WJ, 1991, 12 INT C PHON SCI, V2, P38
[2]  
BASTIAN RW, 1984, NATS B, V40, P26
[3]  
BENNINGER MS, 1993, VOCAL ARTS MED, P295
[4]   Intrasubject variability of objective voice measures [J].
Bough, ID ;
Heuer, RJ ;
Sataloff, RT ;
Hills, JR ;
Cater, JR .
JOURNAL OF VOICE, 1996, 10 (02) :166-174
[5]  
BRADLEY M, 1980, NATS B, V36, P38
[6]  
CARLSON E, 1995, EUR J DISORDER COMM, V30, P140
[7]  
GILLIES HC, 1986, TXB CLIN PHARM, P860
[8]  
HARDMAN JG, 1995, GOODMAN GILMANS PHAR, P670
[9]  
LAWRENCE VL, 1981, NATS B, V37, P23
[10]  
*PCLX, 1992, PCLS LAR MAN